683 related articles for article (PubMed ID: 18510618)
21. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
[TBL] [Abstract][Full Text] [Related]
22. [Nonalcoholic steatohepatitis. Three case reports].
Eivindson MV; Hamilton-Dutoit S; Grønbaek H
Ugeskr Laeger; 2003 Mar; 165(11):1118-20. PubMed ID: 12677986
[TBL] [Abstract][Full Text] [Related]
23. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
24. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
Angulo P; Alba LM; Petrovic LM; Adams LA; Lindor KD; Jensen MD
J Hepatol; 2004 Dec; 41(6):943-9. PubMed ID: 15582127
[TBL] [Abstract][Full Text] [Related]
25. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
26. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
Tiniakos DG
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
[TBL] [Abstract][Full Text] [Related]
28. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
[TBL] [Abstract][Full Text] [Related]
30. Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
Gaens KH; Niessen PM; Rensen SS; Buurman WA; Greve JW; Driessen A; Wolfs MG; Hofker MH; Bloemen JG; Dejong CH; Stehouwer CD; Schalkwijk CG
J Hepatol; 2012 Mar; 56(3):647-55. PubMed ID: 21907687
[TBL] [Abstract][Full Text] [Related]
31. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
[TBL] [Abstract][Full Text] [Related]
32. Bile acid levels are increased in the liver of patients with steatohepatitis.
Aranha MM; Cortez-Pinto H; Costa A; da Silva IB; Camilo ME; de Moura MC; Rodrigues CM
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):519-25. PubMed ID: 18467911
[TBL] [Abstract][Full Text] [Related]
33. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH.
Anty R; Bekri S; Luciani N; Saint-Paul MC; Dahman M; Iannelli A; Amor IB; Staccini-Myx A; Huet PM; Gugenheim J; Sadoul JL; Le Marchand-Brustel Y; Tran A; Gual P
Am J Gastroenterol; 2006 Aug; 101(8):1824-33. PubMed ID: 16790033
[TBL] [Abstract][Full Text] [Related]
34. [Nonalcoholic steatohepatitis--a "new" hepatic disease].
Grønbaek H; Eivindson MV; Hamilton-Dutoit S; Vilstrup H
Ugeskr Laeger; 2003 Mar; 165(11):1115-8. PubMed ID: 12677985
[TBL] [Abstract][Full Text] [Related]
35. Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.
Shindo N; Fujisawa T; Sugimoto K; Nojima K; Oze-Fukai A; Yoshikawa Y; Wang X; Yasuda O; Ikegami H; Rakugi H
J Hepatol; 2010 Jun; 52(6):903-12. PubMed ID: 20392512
[TBL] [Abstract][Full Text] [Related]
36. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease.
Tapan S; Dogru T; Kara M; Ercin CN; Kilciler G; Genc H; Sertoglu E; Acikel C; Kilic S; Karslioglu Y; Kurt I; Erbil MK
Scand J Clin Lab Invest; 2010 Oct; 70(6):399-403. PubMed ID: 20604719
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis.
Koruk M; Tayşi S; Savaş MC; Yilmaz O; Akçay F; Karakök M
Turk J Gastroenterol; 2003 Mar; 14(1):12-7. PubMed ID: 14593532
[TBL] [Abstract][Full Text] [Related]
39. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
[TBL] [Abstract][Full Text] [Related]
40. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.
Bekri S; Gual P; Anty R; Luciani N; Dahman M; Ramesh B; Iannelli A; Staccini-Myx A; Casanova D; Ben Amor I; Saint-Paul MC; Huet PM; Sadoul JL; Gugenheim J; Srai SK; Tran A; Le Marchand-Brustel Y
Gastroenterology; 2006 Sep; 131(3):788-96. PubMed ID: 16952548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
